Leukoplakia
12
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
8%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Topical Imiquimod Treatment of Oral Dysplasia
Vitamin A Status in Patients With Vocal Fold Leukoplakia
Pembrolizumab in Treating Participants With Leukoplakia
Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions
Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial
Natural History of Oro-pharyngeal Cancer Precursors
Photodynamic Therapy for Oral Precursor Lesions
Tobacco Cessation Intervention Study for Oral Diseases
Treatment of Oral Premalignant Lesions With 5-ALA PDT
Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR